A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation

Chinese Medical Journal

Volumn 121, Issue 6, 2008, Pages 498-502

  Qian, Ju Ying ^a   Zhang, Feng ^a   Fan, Bing ^a   Ge, Lei ^a   Wang, Qi Bing ^a   Ge, Jun Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Coronary angioplasty; Drug eluting stents; Incomplete stent apposition; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY STENT; DISEASE CONTROL; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT DURATION;

EID: 41649098187     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803020-00004     Document Type: Article

References (33)

1. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind PAVEL (randomized study with the sirolimus-eluting velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions) trial. Circulation 2002; 106: 798-803.
2. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
4. Zhang F, Ge J, Qian J, Fan B, Wang Q, Ge L, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007; 48: 303-311.
5. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 1002-1005.
6. Mintz G, Weissman NJ, Dawkins K. Frequency, predictors, and clinical outcomes of late-acquired incomplete stent apposition in patients treated with Taxus stents a volumetric intravascular ultrasound meta-analysis from the TAXUS IV, V and VI trials. J Am Coll Cardiol 2006; 47 Suppl 13: 26B.
7. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-419.
8. Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Costa MA, Alfonso F, Gómez-Hospital JA, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial. J Am Coll Cardiol 2006; 47: 2172-2179.
9. Zhang F, Qian JY, Ge JB. Late stent malapposition and marked positive vessel remodeling after sirolimus-eluting coronary stent implantation. Chin Med J 2006; 119: 349-350.
10. Zhang F, Qian JY, Ge JB. Rapid development of late stent malappositon and coronary aneurysm following implantation of a paclitaxel-eluting coronary stent. Chin Med J 2007; 120: 614-616.
11. Qian J, Zhang F, Wu H, Fan B, Ge L, Ge J. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation. Int J Cardiovasc Imaging 2008; 24: 133-139.
12. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003; 108: 2747-2750.
13. Zhang F, Qian JY, Ge JB. Very late stent thrombosis in late stent malapposition after sirolimus-eluting stent implantation. Int Heart J 2007; 48: 591-596.
14. Kozuma K, Costa MA, Sabaté M, Serrano P, van der Giessen WJ, Ligthart JM, et al. Late stent malapposition occurring after intracoronary beta-irradiation detected by IVUS. J Invasive Cardiol 1999; 11: 651-655.
15. Mintz GS, Weissman NJ, Fitzgerald PJ. IVUS assessment of the mechanisms and results of brachytherapy. Circulation 2001; 104: 1320-1325.
16. Virmam R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-705.
17. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
18. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimus-eluting stents following non-cardiac surgery. Catheter Cardiovasc Interven 2005; 65: 516-519.
19. Van der Hoevan BL, Pires NM, Warda HM, Oemrawsingh PV, van Vlijmen BJ, Quax PH, et al. Drug-eluting stents: results, promises and problems. Int J Cardiol 2005; 99: 9-17.
20. Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH Jr. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 2005; 65: 520-524.
21. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
22. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005; 91: e45.
23. Sharifkazemi MB, Zamirian M, Aslani A. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent. Cardiology 2006; 108: 273-274.
24. Yang J, Wang N, Zhang X, Xu J, Ling F, Zhou L, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-713.
25. Henderson D, Gunalingam B. Very late stent thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2006; 68: 406-408.
26. Katayama T, Yamamoto T, Iwasaki Y, Yano K. Two cases of very late stent thrombosis after implantation of a sirolimus-eluting stent presenting as AMI. Int heart J 2007; 48: 393-397.
27. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006; 119: 1056-1061.
28. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
29. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-1113.
30. Feres F, Costa JR Jr, Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 2006; 68: 83-88.
31. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol. 2006; 48: 193-202.
32. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434.
33. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004; 44: 1373-1385.